[Federal Register Volume 87, Number 122 (Monday, June 27, 2022)]
[Notices]
[Pages 38167-38168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13575]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting. 
The meeting will be open to the public via webcast. For this meeting, 
the TBDWG will review the first draft of chapters for the report and 
further discuss plans for developing the next report to the HHS 
Secretary and Congress on federal tick-borne activities and research, 
taking into consideration the 2018 and 2020 report. The 2022 report 
will address a wide range of topics related to tick-borne diseases, 
such as, surveillance, prevention, diagnosis, diagnostics, and 
treatment; identify advances made in research, as well as overlap and 
gaps in tick-borne disease research; and provide recommendations 
regarding any appropriate changes or improvements to such activities 
and research.

DATES: The public can view the meeting online via webcast on July 19-
20, 2022 from approximately 9:00 a.m. to 5:00 p.m. ET (times are 
tentative and subject to change) each day. The confirmed times and 
agenda items for the meeting

[[Page 38168]]

will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-07-19/index.html 
when this information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E. Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC 20024. Email: <a href="/cdn-cgi/l/email-protection#44302d272f262b362a21202d3721253721042c2c376a232b32"><span class="__cf_email__" data-cfemail="5f2b363c343d302d313a3b362c3a3e2c3a1f37372c71383029">[email protected]</span></a>. 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: A link to view the webcast can be found on 
the meeting website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-07-19/index.html when it becomes 
available. The public will have an opportunity to present their views 
to the TBDWG orally during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-07-19/index.html and 
respond by midnight July 11, 2022 ET. Verbal comments will be limited 
to three minutes each to accommodate as many speakers as possible 
during the 30-minute session. Written public comments will be 
accessible to the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.

    Dated: June 7, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-13575 Filed 6-24-22; 8:45 am]
BILLING CODE 4150-28-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>